Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
about
Biomarkers in Multiple Sclerosis: An Up-to-Date OverviewIL-23: changing the verdict on IL-12 function in inflammation and autoimmunityClinical, MRI, and CSF markers of disability progression in multiple sclerosis.Potential Blood-based Biomarkers for Concussion.N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosisA novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseasesIdentification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation.Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients.Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.Biomarkers in chronic adult hydrocephalus.Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion.Cerebrospinal Fluid Biomarkers of Japanese EncephalitisSera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairmentGelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.Homocysteine in relation to cognitive performance in pathological and non-pathological conditions.Toward biomarkers in multiple sclerosis: new advances.CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.Biomarkers of HIV-1 associated dementia: proteomic investigation of sera.Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosisSerum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementiaSerum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis.Proteome analysis of schizophrenia brain tissue.Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity.Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?Neurofilaments as biomarkers in multiple sclerosis.Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.Neuroproteomic profiling of human body fluids.Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences.Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.
P2860
Q27496017-898608B1-9078-4A75-8CF4-E961D6538EE5Q28282812-EED0023C-8312-4F59-8E2B-89B2723184DFQ30712257-B233C5AE-1E93-4238-8153-4974D4433E47Q31119100-D973AA77-0D12-4592-B1F7-CB2B36EA1C2EQ33556095-8D772582-F9F6-4C26-87F5-38B309220F8FQ33731693-E42DBA5E-CF05-4690-A29C-629431C6AC16Q33735371-EFEA0760-56CF-45D0-A9DF-5E2D800334F2Q33851008-589277A3-B2D9-4AB8-807B-B893BF634F21Q33877162-5F89387C-9B2F-4AAB-96D6-CF238EBFD43FQ33960847-A75503ED-6D28-4F5A-A169-07FCED5AB7E9Q34078026-60C9DBF2-683E-4070-904E-77520BC60F21Q34570124-F3A40306-1748-448E-B190-1933E7C6FAF2Q34577625-875709FA-EE28-4CBF-8536-814A34809199Q34652734-FEE5A28A-CD5D-4861-8E3F-B33A8119543AQ35101048-8AC6223E-9127-421B-9C9E-5CC4AEEFF149Q35250966-0A3EA7DE-1643-4B1B-A0FD-8E912EF4C6D8Q35589772-56B60254-83F5-43EB-BD47-5C8A6458A4CAQ35953808-6A29241B-5569-4DFB-935D-E7B7A0F8A993Q36121837-E3799F51-945E-4FD6-88F7-0DED87242445Q36129472-BD46BB3B-0EC6-4A3B-A8FE-838F6399DC21Q36273343-3AE5EB87-9FA6-43F8-996C-95A4B4F604B6Q36492380-BEDA2E36-ACE3-4F79-9776-C2BF1E3F2CDFQ36840016-461CB0B4-7206-4DF7-9151-7D12E198217CQ37152990-33520AF9-76A8-4C22-A38B-1AA5F862D3B6Q37206262-97867E13-055F-40AB-AD15-7CA22B9D6947Q37251032-AD94AAE4-106A-4402-B371-9372F5946E00Q37304614-DBF12BA5-F1A9-4985-992C-DF17250320FAQ37370757-015A262B-D13B-4671-9E0C-F9C08AC83DA7Q37682924-FF1CF55D-F4C2-4143-A13A-EF968E9FE4BCQ37755142-39ACE71D-C6C4-4F3D-ADB9-2923DD438B42Q37969082-636C074D-BD84-4AB6-8E1A-B1DC57D9A3C7Q38001602-9096C7C1-8A14-4610-888B-75ECB2F24B1DQ38109663-C0F9C058-9337-49F2-9010-635AD8F70DA4Q38140023-5D3A3BCC-CE81-4D38-9CEE-86A502D1F993Q38186206-D4855005-CB36-4887-8766-40B0C00CECE8Q38569255-0B813630-B87C-4731-AD48-2C82086CCB00Q38644674-3044C788-EE6C-4BBC-8E00-18B982CC3F1EQ38782456-AF8377DD-FD35-466F-B948-094B2767AACAQ39996618-638AD161-D53E-4245-8465-D74AFC78FCD7Q40505202-D8775DBF-6E17-4705-A004-68BD89A24BB0
P2860
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@ast
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@en
type
label
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@ast
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@en
prefLabel
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@ast
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@en
P2093
P1433
P1476
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
@en
P2093
Charlotte E Teunissen
Chris Polman
Christine Dijkstra
P356
10.1016/S1474-4422(04)00964-0
P577
2005-01-01T00:00:00Z